The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study-Reference-Cited by-同舟云学术

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study

Published:2022-02-17 Issue:1 Volume:157 Page:177-185
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Ramos-Fresnedo Andres,Pullen Michael W.,Perez-Vega Carlos,Domingo Ricardo A.,Akinduro Oluwaseun O.,Almeida Joao P.,Suarez-Meade Paola,Marenco-Hillembrand Lina,Jentoft Mark E.,Bendok Bernard R.,Trifiletti Daniel M.,Chaichana Kaisorn L.,Porter Alyx B.,Quiñones-Hinojosa Alfredo,Burns Terence C.,Kizilbash Sani H.,Middlebrooks Erik H.,Sherman Wendy J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-03960-6.pdf

Reference35 articles.

1. Aibaidula A, Chan AK, Shi Z, Li Y, Zhang R, Yang R, Li KK, Chung NY, Yao Y, Zhou L, Wu J, Chen H, Ng HK (2017) Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol 19:1327–1337. https://doi.org/10.1093/neuonc/nox078

2. Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A (2018) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 20:66–77. https://doi.org/10.1093/neuonc/nox132

3. Hirose Y, Sasaki H, Abe M, Hattori N, Adachi K, Nishiyama Y, Nagahisa S, Hayashi T, Hasegawa M, Yoshida K (2013) Subgrouping of gliomas on the basis of genetic profiles. Brain Tumor Pathol 30:203–208. https://doi.org/10.1007/s10014-013-0148-y

4. Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DTW, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, Platten M, Paulus W, Reifenberger G, Tonn J-C, Aldape K, Pfister SM, Korshunov A, Weller M, Herold-Mende C, Wick W, Brandner S, von Deimling A (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407–417. https://doi.org/10.1007/s00401-015-1454-8

5. Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M, Reifenberger G, Weller M, Hänggi D, Wick W, Herold-Mende C, Westphal M, Brandner S, Pfister SM, Capper D, Sahm F, von Deimling A (2018) Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol 136:793–803. https://doi.org/10.1007/s00401-018-1905-0

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal instability: a key driver in glioma pathogenesis and progression;European Journal of Medical Research;2024-09-04

2. Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone;Science Advances;2024-08-09

3. Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance;Journal of Neuro-Oncology;2024-08-08

4. Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach;Journal of Neuro-Oncology;2024-07-22

5. Nomogram of magnetic resonance imaging (MRI) histogram analysis to predict telomerase reverse transcriptase promoter mutation status in glioblastoma;Quantitative Imaging in Medicine and Surgery;2024-07